logo

ELTX

Elicio Therapeutics·NASDAQ
--
--(--)
--
--(--)

ELTX fundamentals

Elicio Therapeutics (ELTX) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.6 (YoY +56.83%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.6
+56.83%
Report date
Nov 13, 2025
EPS
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-19-15.6-5.8-5.35-4.8-3-3-2.61-1.27-1.25-1.15-0.64-1.39-1.07-0.87-0.66-0.6
Forecast
-13.225-6.225-6.875-7.25-3.275-4.35-4.6333-3.2-5.4-5.7-0.8-1.03-1.09-0.96-0.73-0.875-0.83-0.685-0.48
Surprise
-43.67%
-150.60%
+15.64%
+26.90%
+252.67%
-10.34%
+35.25%
+6.25%
0.00%
+54.21%
-58.75%
-21.36%
-5.50%
+33.33%
-90.41%
-22.29%
-4.82%
+3.65%
-25.00%
Revenue
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
479.50K371.00K540.00K1.46M25.90M1.65M653.00K0--0000000000
Forecast
753.00K1.89M787.50K1.06M7.41M918.75K1.35M625.00K800.00K800.00K000000000
Surprise
-36.32%
-80.34%
-31.43%
+37.41%
+249.52%
+79.37%
-51.63%
-100.00%
0.00%
-100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call